Can hepatitis B be cured? What is the best way to treat hepatitis B at present?

Hepatitis B is a common disease. Most of the existing cases of hepatitis B are chronic virus carriers (about 80%). Even if you don't take medicine, most of them have a good prognosis and can spend their lives safely. Hepatitis B patients who are in the state of onset can be controlled if they are given cheap and effective treatment. Although hepatitis B is contagious, it only poses a threat to infants and children. As long as everyone is vaccinated against hepatitis B, it is difficult for hepatitis B virus to pose a threat. Those rare and real acute hepatitis B, 90% will be cured, leaving no future trouble. The following further explains why hepatitis B is a common disease. 1. Hepatitis B is very common and common in China, which is related to China's vast territory, numerous nationalities, national physique, genetic characteristics and susceptibility to hepatitis B virus. According to the characteristics, symptoms and signs of hepatitis B, it is likely that the disease has existed since ancient times. For a long time, the disease has brought many influences and harms to human life, but these harms are limited and by no means a disaster. From a global perspective, the United States in Western Europe is a low-incidence area, Japan and Eastern Europe are middle-incidence areas, and China and Southeast Asia are high-incidence areas. The positive rate of hepatitis B surface antigen accounts for about one tenth of the total population in China, and the positive rate of hepatitis B virus surface antigen varies among different ethnic groups, among which Tibetans are the highest (accounting for about 27% of the total population), Han people are in the middle (about 15%) and Uighurs are the lowest (about 2%). This high incidence of hepatitis B is not only today, but also the result of several general surveys in China decades ago (after the appearance of surface antigen). The number of cases of hepatitis B increases with the increase of population base, and the cases that take their lives due to the development of hepatitis B are severe hepatitis, advanced cirrhosis and liver cancer. These three diseases are very serious, but hepatitis B, which has really developed to this stage, is a minority after all. 1000 patients with hepatitis B will eventually develop liver cancer, 15 patients will eventually develop cirrhosis, 1.2-2 patients will develop severe hepatitis, and the remaining 900 patients can live a stable life. At present, there are more than 300 million hepatitis B patients worldwide. We have never heard of the outbreak and prevalence of hepatitis B. We have never heard of a country, a nation or a region whose life expectancy has been reduced and the death rate has increased because of hepatitis B. The incidence of hepatitis B in Southeast Asian countries has surpassed that of China, but we have never seen anyone treated for two days, and we have never heard of this kind of medicine for treating hepatitis B constantly appearing in these countries. The life expectancy of the population in Southeast Asia is still increasing. Hepatitis B is a common disease. Like hypertension, bronchitis, nephritis, etc. Most patients can be stable in the "sub-health" state, and only a few patients develop into a life-threatening serious state. The infectivity of hepatitis B is not as terrible as people imagine and legend. Although it is widespread, its infectious harm is limited and it will not cause outbreaks and epidemics. Fetuses, infants and children are the biggest victims of infectious diseases and the people who are most threatened by infectious diseases. It is difficult for hepatitis B virus to pose a threat to adults. The infectivity of hepatitis B virus is inversely proportional to the age of the infected person. The younger the infected person is, the higher the probability of successful infection. Fetal infection in the uterus of pregnant women is called intrauterine infection of hepatitis B virus. Once infected in the uterus, it will almost become a chronic virus carrier, and this virus infection is often deeply rooted and difficult to cure. Once the newborn is infected with hepatitis B virus during delivery, if hepatitis B vaccine and hepatitis B immunoglobulin are not given in time, the virus can also be directly driven indoors, leaving a lifelong hidden danger; On the other hand, when an adult is infected with hepatitis B virus, less than 5% of people will be infected successfully. The vast majority of adults can rely on their normal immune mechanism to "keep the enemy out of the country" and clear and destroy hepatitis B virus in time, so that it has no hiding place. Where does so much hepatitis B come from in China? Basically, they are infected from childhood, and the route is vertical transmission from mother to child or from father to baby. A small number of them are infected through medical channels (blood transfusion, infusion, tooth implantation, acupuncture, etc.). ) .3. The vast majority of patients with hepatitis B are virus carriers and mild hepatitis, with a good prognosis, and most of them can spend their lives safely. Although there are a large number of hepatitis B patients in China, more than 80% of them are virus carriers and mild hepatitis. Most of them developed steadily or slowly, and the liver lesions were static or mild. I'm not sick. If I don't have a physical examination (conscription, enrollment, joining the army, donating blood, etc.). ), I can't find it at all, and I may live a stable life unconsciously. Judging from the authoritative research results at present, the prognosis of virus carriers and mild chronic hepatitis is mostly good, and they may eventually die of some diseases unrelated to liver disease. Therefore, patients in these two situations should try their best to maintain their original healthy life and work style, strive for psychological balance and mental stability, and avoid indiscriminate medication. 4. There are indeed a few patients who develop into active hepatitis, liver cirrhosis and even liver cancer. The objective reasons are genetic factors, low immune status, virus gene variation, new hepatitis virus superposition and so on. The subjective reason is that patients torture themselves and use drugs indiscriminately. Objective factors are not transferred by human will; Subjective factors are artificial and can be eliminated. The so-called patient tortures himself mainly means that the patient can't treat the disease correctly: people who are too nervous are restless and suffer physically and mentally; Those who are too optimistic, let themselves go, indulge themselves by drinking and ignore them. Coupled with the indiscriminate use of drugs, credulous advertising, and the temptation of others, I really hope to use this medicine today and that medicine tomorrow. From this point of view, half of the reasons for the aggravation of the disease are objective and the other half are man-made. An ordinary disease, which was originally nothing, has become a disease that continues to deteriorate after being tossed around by people. At present, there is no breakthrough in treatment, but preventive measures are guaranteed. If prevention is given priority to and planned immunization against hepatitis B is implemented, the incidence of hepatitis B in China will drop rapidly. In another 50 years, the hat of the "kingdom" of hepatitis B will be removed. Looking back on the history of infectious diseases in the past century, smallpox, tetanus and polio were rampant in the early 20 th century, and all kinds of drugs were difficult to work. In the end, these diseases gradually became extinct, not by treatment, but by prevention. The advent of various vaccines and the implementation of compulsory planned immunization have completely eradicated these evils, and so has hepatitis B now. The key to eradicate it is to popularize hepatitis B vaccine, which is not only feasible in theory, but also quite easy to operate in practice. Regrettably, so far, the society has not fully understood the significance of hepatitis B prevention. Although hepatitis B vaccine is included in the planned immunization, it is not mandatory. From the national situation, two-thirds of the population have not been vaccinated against hepatitis B, but they are particularly enthusiastic about the treatment of hepatitis B. Therapeutic drugs are constantly emerging, the cost of treatment is rising all the way, and the treatment effect is always poor. This cannot be said to be putting the cart before the horse. If you don't put the prevention of hepatitis B in the first place, 6. Hepatitis B is like a plague in the eyes of the general public and patients. Once you find yourself positive for hepatitis B, you panic, run around and spend money on treatment, which has almost become a stereotype. Why? Exaggerating the harm and threat of hepatitis B, exaggerating the infectivity of hepatitis B and unreasonably limiting the future of patients with hepatitis B are the fundamental reasons for these abnormalities. Hepatitis B is a chronic disease and a common disease, but the treatment and treatment of the disease and the content of media publicity in China deserve reflection and in-depth study. Developed countries, such as Japan and Singapore; Developing countries, such as Thailand and Malaysia; As well as Hongkong and Taiwan Province provinces in China, the incidence of hepatitis B is not low, and there are many patients. But their ways and attitudes towards hepatitis B are different from those in China. Other countries rarely exaggerate the horror and horror of this disease in the media. Patients with hepatitis B generally work and study normally, and there are no special restrictions on study and work, not to mention various treatments. In Hongkong, there are few legal and approved drugs to treat hepatitis B, and so is Taiwan Province Province. First, the prevention work is well done, and the vaccination rate of hepatitis B vaccine is high; Second, patients can avoid additional drug-induced liver injury without messy treatment drugs. China has the same example. One out of every four Tibetan compatriots in China suffers from hepatitis B, that is, I have never heard that Tibetan compatriots are running around seeking medical treatment, nor have I heard that the average life expectancy of Tibetans is threatened by hepatitis. Carrying hepatitis B virus is one of the common phenomena in China. We must look at this problem realistically. The only way to eradicate this phenomenon is to make hepatitis B vaccine compulsory throughout the country. We must not follow the footsteps of Europe and America on the issue of hepatitis B, resulting in a situation of "high consumption in poor countries". The hepatitis B market in China is extremely hot, with a large number of foreign medicines and local medicines. Unfortunately, most patients are wasting people's money, but they never see the light. This is related to the misunderstanding and misleading of hepatitis B in China. Therefore, it is necessary to restore the true colors of hepatitis B, let all patients know the truth, and treat hepatitis B as a common disease, not a "plague".